Pharmaceutical Computer Systems Validation


Book Description

Thoroughly revised to include the latest industry developments, the Second Edition presents a comprehensive overview of computer validation and verification principles and how to put them into practice. To provide the current best practice and guidance on identifying and implementing improvements for computer systems, the text extensively reviews regulations of pharmaceuticals, healthcare products, blood processing, medical devices, clinical systems, and biotechnology. Ensuring that organizations transition smoothly to the new system, this guide explains how to implement the new GMP paradigm while maintaining continuity with current practices. In addition, all 24 case studies from the previous edition have been revised to reflect the new system.




Pharmaceutical and Medical Devices Manufacturing Computer Systems Validation


Book Description

Validation of computer systems is the process that assures the formal assessment and report of quality and performance measures for all the life-cycle stages of software and system development, its implementation, qualification and acceptance, operation, modification, requalification, maintenance and retirement (PICS CSV PI 011-3). It is a process that demonstrates the compliance of computer systems functional and non-functional requirements, data integrity, regulated company procedures and safety requirements, industry standards, and applicable regulatory authority’s requirements. Compliance is a state of being in adherence to application-related standards or conventions or regulations in laws and similar prescriptions. This book, which is relevant to the pharmaceutical and medical devices regulated operations, provides practical information to assist in the computer validation to production systems, while highlighting and efficiently integrating worldwide regulation into the subject. A practical approach is presented to increase efficiency and to ensure that the validation of computer systems is correctly achieved.




EU Annex 11 Guide to Computer Validation Compliance for the Worldwide Health Agency GMP


Book Description

Good Manufacturing Practice (GMP) ensures medicinal products are produced consistently and controlled to the quality standards appropriate for their intended use and as required by product specifications or marketing authorization. Annex 11 details the European Medicines Agency (EMA) GMP requirements for computer systems.The purpose of Annex 11 is




Computer System Validation and GAMP 5


Book Description

The purpose of this book is to help you understand how computerized systems are validated using the GAMP5framework. The information will be presented in a project life cycle format. This will give you a solid idea howComputerized System Validation projects are conducted. This book is suited for anyone new to Computer SystemsValidation. It is written in a simple manner and can serve as starter guide which includes many high-level sample templates and illustration.




GAMP 5


Book Description

GAMP 5 provides pragmatic and practical industry guidance to achieve compliant computerized systems fit for intended use in an efficient and effective manner. This technical document describes a flexible risk-based approach to compliant GxP regulated computerized systems, based on scalable specification and verification. It points to the future of computer systems compliance by centering on principles behind major industry developments such as PQLI; ICH Q8, Q9, Q10; and ASTM E2500. This revolutionary Guide addresses the entire lifecycle of an automated system and its applicability to a wide range of information systems, lab equipment, integrated manufacturing systems, and IT infrastructures. It contains new information on outsourcing, electronic batch recording, end user applications (such as spreadsheets and small database applications), and patch management.




Validation of Pharmaceutical Processes


Book Description

Completely revised and updated to reflect the significant advances in pharmaceutical production and regulatory expectations, this third edition of Validation of Pharmaceutical Processes examines and blueprints every step of the validation process needed to remain compliant and competitive. The many chapters added to the prior compilation examine va




Validation of Chromatography Data Systems


Book Description

Guiding chromatographers working in regulated industries and helping them to validate their chromatography data systems to meet data integrity, business and regulatory needs. This book is a detailed look at the life cycle and documented evidence required to ensure a system is fit for purpose throughout the lifecycle. Initially providing the regulatory, data integrity and system life cycle requirements for computerised system validation, the book then develops into a guide on planning, specifying, managing risk, configuring and testing a chromatography data system before release. This is followed by operational aspects such as training, integration and IT support and finally retirement. All areas are discussed in detail with case studies and practical examples provided as appropriate. The book has been carefully written and is right up to date including recently released FDA data integrity guidance. It provides detailed guidance on good practice and expands on the first edition making it an invaluable addition to a chromatographer’s book shelf.







Software Development Patterns and Antipatterns


Book Description

Software development has been a troubling since it first started. There are seven chronic problems that have plagued it from the beginning: Incomplete and ambiguous user requirements that grow by >2% per month. Major cost and schedule overruns for large applications > 35% higher than planned. Low defect removal efficiency (DRE) Cancelled projects that are not completed: > 30% above 10,000 function points. Poor quality and low reliability after the software is delivered: > 5 bugs per FP. Breach of contract litigation against software outsource vendors. Expensive maintenance and enhancement costs after delivery. These are endemic problems for software executives, software engineers and software customers but they are not insurmountable. In Software Development Patterns and Antipatterns, software engineering and metrics pioneer Capers Jones presents technical solutions for all seven. The solutions involve moving from harmful patterns of software development to effective patterns of software development. The first section of the book examines common software development problems that have been observed in many companies and government agencies. The data on the problems comes from consulting studies, breach of contract lawsuits, and the literature on major software failures. This section considers the factors involved with cost overruns, schedule delays, canceled projects, poor quality, and expensive maintenance after deployment. The second section shows patterns that lead to software success. The data comes from actual companies. The section’s first chapter on Corporate Software Risk Reduction in a Fortune 500 company was based on a major telecom company whose CEO was troubled by repeated software failures. The other chapters in this section deal with methods of achieving excellence, as well as measures that can prove excellence to C-level executives, and with continuing excellence through the maintenance cycle as well as for software development.